GHRS

GH Research (GHRS)

About GH Research (GHRS)

GH Research Plc is a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients with psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.

Details

Daily high

$13.53

Daily low

$12.77

Price at open

$13.06

52 Week High

$19.51

52 Week Low

$7.98

Market cap

830.6M

Dividend yield

0.00%

Volume

104,182

Avg. volume

241,147

P/E ratio

-16.95

GH Research News